Clínica de Marly Income Statement

Financials in millions COP. Fiscal year is January - December.

Millions COP. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	442,007	435,862	413,169	362,905	321,343	278,599
Revenue Growth (YoY)	4.67%	5.49%	13.85%	12.93%	15.34%	32.81%
Cost of Revenue	275,742	271,418	256,982	231,992	208,407	178,364
Gross Profit	166,265	164,444	156,187	130,913	112,935	100,234
Selling, General & Admin	70,270	69,489	40,774	36,964	33,870	28,018
Amortization of Goodwill & Intangibles	-	-	904.1	849.82	492.11	401.94
Other Operating Expenses	-	-	5,608	5,453	3,985	3,091
Operating Expenses	70,270	69,489	52,087	47,948	43,641	36,557
Operating Income	95,994	94,955	104,100	82,965	69,294	63,678
Interest Expense	-6,382	-6,768	-1,364	-2,324	-2,206	-1,608
Interest & Investment Income	21,560	21,560	16,025	12,491	5,805	1,749
Earnings From Equity Investments	-	-	36,628	21,135	19,381	18,419
Currency Exchange Gain (Loss)	-	-	2,345	-3,530	2,616	2,421
Other Non Operating Income (Expenses)	20,131	18,647	-21,831	-8,019	-12,403	-12,456
EBT Excluding Unusual Items	131,303	128,394	135,903	102,718	82,487	72,203
Gain (Loss) on Sale of Investments	-	-	233.45	-	-	-
Gain (Loss) on Sale of Assets	-	-	-	-	-	26.91
Asset Writedown	-	-	-8,460	-7,413	-550.3	-1,958
Pretax Income	131,303	128,394	127,676	95,306	81,936	70,271
Income Tax Expense	40,692	40,362	38,820	30,536	26,642	20,467
Earnings From Continuing Operations	90,611	88,032	88,856	64,770	55,295	49,804
Minority Interest in Earnings	-791.04	-597.59	-1,121	-89.46	-713.74	-830.06
Net Income	89,820	87,435	87,735	64,681	54,581	48,974
Net Income to Common	89,820	87,435	87,735	64,681	54,581	48,974
Net Income Growth	-0.10%	-0.34%	35.64%	18.50%	11.45%	78.41%
Shares Outstanding (Basic)	-	-	-	11	11	11
Shares Outstanding (Diluted)	-	-	-	11	11	11
EPS (Basic)	-	-	-	6057.41	5111.57	4586.50
EPS (Diluted)	-	-	-	6057.41	5111.57	4586.50
EPS Growth	-	-	-	18.50%	11.45%	78.41%
Free Cash Flow	16,748	31,264	-422.9	23,300	27,495	16,504
Free Cash Flow Per Share	-	-	-	2182.04	2574.90	1545.65
Dividend Per Share	-	-	1596.000	1200.000	696.000	564.000
Dividend Growth	-	-	33.00%	72.41%	23.40%	-
Gross Margin	37.62%	37.73%	37.80%	36.07%	35.14%	35.98%
Operating Margin	21.72%	21.79%	25.20%	22.86%	21.56%	22.86%
Profit Margin	20.32%	20.06%	21.23%	17.82%	16.98%	17.58%
Free Cash Flow Margin	3.79%	7.17%	-0.10%	6.42%	8.56%	5.92%
EBITDA	-	100,677	109,736	88,446	75,033	69,075
EBITDA Margin	-	23.10%	26.56%	24.37%	23.35%	24.79%
D&A For EBITDA	-	5,722	5,635	5,480	5,739	5,397
EBIT	95,994	94,955	104,100	82,965	69,294	63,678
EBIT Margin	21.72%	21.79%	25.20%	22.86%	21.56%	22.86%
Effective Tax Rate	30.99%	31.44%	30.40%	32.04%	32.52%	29.13%